Video: New vaccine to protect babies from whooping cough

by David Hover

Whooping cough, also known as pertussis, is a bacterial infection that can be fatal. Now, a new nasal vaccination aimed at infants aims to address an unmet medical need against this disease.

In Europe, (Pertussis) is in the increase, with more than 20.000 cases reported annually. Often infants fall victim to the disease, where it can be life-threatening. Possible complications include pneumonia, and collapsed lungs, leading to death in one in 200.

There is a vaccine on the market, but a newborn's immune system is too immature to respond to it. Therefore scientists at the Institute Pasteur in Lille, France have developed a new vaccine that the babies' immune system can deal with: it is administered intranasally to reproduce the natural conditions of infection as closely as possible. The new substance is currently undergoing clinical trials and has passed the first phase of testing on human adults successfully. The results were published on the last issue of the peer-reviewed journal Plos One.

This video is not supported by your browser at this time.

Read more: Camille Locht: An innovative solution to infant whooping cough

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Study recalculates costs of combination vaccines

Apr 17, 2014

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Drug watchdog urges vigilance in cancer drug theft

Apr 17, 2014

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

User comments